1. Home
  2. PNTG vs PCRX Comparison

PNTG vs PCRX Comparison

Compare PNTG & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Pennant Group Inc.

PNTG

The Pennant Group Inc.

HOLD

Current Price

$30.38

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Logo Pacira BioSciences Inc.

PCRX

Pacira BioSciences Inc.

HOLD

Current Price

$20.94

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PNTG
PCRX
Founded
2019
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Nursing Services
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.0B
IPO Year
N/A
2011

Fundamental Metrics

Financial Performance
Metric
PNTG
PCRX
Price
$30.38
$20.94
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
6
Target Price
$36.50
$35.33
AVG Volume (30 Days)
334.2K
1.0M
Earning Date
02-26-2026
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
10.47
N/A
EPS
0.75
0.47
Revenue
$847,274,000.00
$716,791,000.00
Revenue This Year
$36.42
$6.21
Revenue Next Year
$23.99
$8.26
P/E Ratio
$40.37
$44.56
Revenue Growth
29.89
3.14
52 Week Low
$21.18
$18.80
52 Week High
$31.94
$27.64

Technical Indicators

Market Signals
Indicator
PNTG
PCRX
Relative Strength Index (RSI) 58.41 42.88
Support Level $26.67 $20.24
Resistance Level $30.53 $21.60
Average True Range (ATR) 1.40 0.83
MACD 0.08 0.15
Stochastic Oscillator 67.68 70.00

Price Performance

Historical Comparison
PNTG
PCRX

About PNTG The Pennant Group Inc.

Pennant Group Inc is engaged in providing healthcare services to patients of all ages, including the growing senior population, in the United States. It operates in multiple lines of business including home health, hospice, and senior living which includes the company's assisted living, independent living, and memory care communities across Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The company generates majority of its revenue from home health and hospice services segment, which includes its home health, hospice and home care businesses.

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

Share on Social Networks: